Solid Biosciences Inc.SLDBNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-61.66%
↓ 25% below average
Average (9y)
-49.23%
Historical baseline
Range
High:-0.97%
Low:-220.53%
CAGR
+58.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -61.66% | +21.3% |
| 2023 | -78.38% | +64.5% |
| 2022 | -220.53% | -421.3% |
| 2021 | -42.30% | -189.6% |
| 2020 | -14.61% | +73.0% |
| 2019 | -54.16% | -519.3% |
| 2018 | -8.74% | -40.1% |
| 2017 | -6.24% | -32.3% |
| 2016 | -4.72% | -387.9% |
| 2015 | -0.97% | - |